-

W2O Appoints Bryan Specht to Oversee Transformation, Consumer Activation and Marketing

Accelerates Firm’s Evolution to Drive Consumerization and Digitization of Healthcare

SAN FRANCISCO--(BUSINESS WIRE)--W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, announced today that Bryan Specht has been named Group President, Transformation, Consumer Activation and Marketing. In this role, he will expand W2O’s healthcare offering to include additional consumer-focused, tech-enabled and digital capabilities, accelerating its transformation to a digital healthcare firm.

With five acquisitions in the past seven months, W2O has been readying for further disruption and consumerization of healthcare, which has been accelerated by the COVID-19 pandemic. Specht will lead integration of people and technology across the firm, creating new ways to work with clients and potential partners to redefine how people experience healthcare and manage their personal health. A recognized transformation leader, Specht brings deep understanding of change management to accelerate W2O’s evolution.

“Current events are escalating the disruption and transformation happening in the healthcare industry, which is leveraging telemedicine, genomics and other data-based, digital experiences to improve people’s health and wellness,” said Jim Weiss, Founder and CEO of W2O. “Bryan understands the human side of healthcare and that patients expect real-time, personal and direct access to health information. As a firm, we have been on a journey to infuse the marketing principles of the consumer and influence world with science and healthcare to reach people in new ways, giving them more control to live healthier lives. Bryan will accelerate and dimensionalize these assets, resulting in a truly digital healthcare firm.”

Specht previously served as Chief Growth and Innovation Officer and was a key architect in launching ICF Next, a global consulting agency built through the convergence of 10 different award-winning marketing, engagement and digital businesses. Before ICF, Specht was president of Olson, overseeing the firm as it received a long list of industry honors including multiple agency of the year distinctions and more than a dozen Cannes Lions. A respected thought leader and change agent in the industry, he was three times named to PRWeek’s Power 50 List and was named to PRovoke’s Innovator 25.

“I am energized by the purpose, entrepreneurialism and incredible 18-year track record of double-digit growth at W2O,” said Specht. “Now is the time to harness W2O’s technology, data, creativity and marketing communications expertise to deliver some of the most important and meaningful engagement in the lives of people each and every day. As we’re witnessing with the current pandemic, W2O’s mission to make the world a healthier place through marketing communications has never been more important.”

About W2O

Founded by Jim Weiss in 2001, W2O is the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector. W2O applies proprietary analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. The firm employs nearly 1,400 people in 18 offices across the United States and in Europe, and partners with a growing roster of Fortune 500 organizations, including 23 of the top 25 pharmaceutical companies.

For more information, please visit www.w2ogroup.com.

Follow W2O on Twitter
Follow W2O on LinkedIn
Follow W2O on Facebook

Contacts

Peter Duckler, 310-774-3425
pduckler@w2ogroup.com

W2O


Release Summary
W2O announced today that Bryan Specht has been named Group President of Transformation, Consumer Activation, and Marketing.
Release Versions

Contacts

Peter Duckler, 310-774-3425
pduckler@w2ogroup.com

Social Media Profiles
More News From W2O

SUO and Ferring Pharmaceuticals Announce the SUO Non-Muscle Invasive Bladder Cancer (NMIBC) Fellows Research Grant

SCHAUMBURG, Ill. & PARSIPPANY, N.J.--(BUSINESS WIRE)--The Society of Urologic Oncology (SUO) and Ferring Pharmaceuticals today announced the SUO NMIBC (non-muscle invasive bladder cancer) Fellows Research Grant, created to support outstanding clinical research investigators committed to advancing the understanding and treatment of NMIBC. Two applicants will receive the SUO NMIBC Fellows Research Grant, provided by an educational grant from Ferring Pharmaceuticals. “Advancing research in NMIBC i...

Real Chemistry Strengthens Media and Omnichannel Leadership with Acquisition of Spring & Bond

NEW YORK--(BUSINESS WIRE)--Real Chemistry continues to strengthen its media capabilities by acquiring Spring & Bond....

Real Chemistry Appoints Meenakshi Yadav as Chief AI Products and Solutions Officer

NEW YORK--(BUSINESS WIRE)--Real Chemistry announces Meenakshi Yadav as Chief AI Products and Solutions Officer, marking a strategic leap in its AI journey....
Back to Newsroom